| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |